Saturday, November 14

Health

Rajasthan: Chief Secy directs stronger support for timely transport of pregnant women

Rajasthan: Chief Secy directs stronger support for timely transport of pregnant women

Health
Jaipur, Oct 3 (IANS) Rajasthan Chief Secretary V. Srinivas on Saturday reviewed the operation and management of the ‘104 Janani Express’ service at the Government Secretariat and directed officials to strengthen arrangements for transporting pregnant women, particularly those with high-risk pregnancies, to hospitals on time.The Chief Secretary stressed the need for better coordination between maternal healthcare services and the Janani Express service to ensure timely transportation during emergencies.Srinivas directed officials to regularly assess the utilisation of each ambulance and identify areas for improvement based on reports from the field.He emphasised strengthening local-level operational arrangements, so available ambulances can be utilised more effectively, and women in need ...
India to become global leader in robotic surgery: JP Nadda

India to become global leader in robotic surgery: JP Nadda

Health
New Delhi, Oct 3 (IANS) Union Minister for Health and Family Welfare, JP Nadda, has said that India is increasingly becoming an important global destination for healthcare innovation and advanced surgical technology.“India stands at an exciting juncture in healthcare innovation, with our strength in technology, artificial intelligence, digital health and a rapidly expanding ecosystem of surgical robotics," the minister said in his virtual address during the international conference on Robotic Surgery held by the Society of Robotic Surgery (SRS).The minister said that India holds the opportunity to innovate, develop and lead this future technology.India is rapidly becoming a major centre for robotic surgery, with Delhi-NCR leading the country in robotic-system installations and surgical vol...
Maharashtra FDA cancels Cipla Warehouse Pune licence over alleged packaging, storage lapses

Maharashtra FDA cancels Cipla Warehouse Pune licence over alleged packaging, storage lapses

Health
Mumbai, Oct 2 (IANS) The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale and distribution licences of Cipla Pharma & Life Sciences Ltd's carrying and forwarding (C&F) warehouse in Wadki, Pune, citing a series of alleged regulatory violations related to drug packaging, storage conditions, inventory management and documentation.The licence cancellation order was issued on October 1 by the Assistant Commissioner (Drugs), Division 3, Pune, following a fresh review conducted in accordance with directions from the Bombay High Court.The latest action comes after earlier proceedings initiated against the facility on August 27 were withdrawn and reconsidered under a revised regulatory process.According to the FDA, the earlier action had raised concerns over the pa...
Major blast, fire at Mangaluru Refinery and Petrochemicals unit leaves 8 injured

Major blast, fire at Mangaluru Refinery and Petrochemicals unit leaves 8 injured

Health
Mangaluru, Sep 30 (IANS) A major blast, followed by a fire, was reported at the Mangalore Refinery and Petrochemicals Ltd in Karnataka's Mangaluru on Wednesday, but the blaze has been brought under control, Police Commissioner Sudheer Kumar Reddy said.According to the Commissioner, two persons were seriously injured in the incident.One of them, identified as Rajesh Baptist, who was present inside the plant, suffered burn injuries to around 35 per cent of his body. He was shifted to Srinivasa Hospital for treatment and is currently in the ICU. Doctors have said that he is out of danger.Six other persons who sustained minor injuries in an adjacent office were given treatment and underwent check-ups on an outpatient basis, the Commissioner said.The Police Commissioner, the Deputy Commissioner...
India’s Ayush services economy could scale up to $318 billion by 2047

India’s Ayush services economy could scale up to $318 billion by 2047

Health
New Delhi, Sep 30 (IANS) The Ayush services sector contributed an estimated $36.92 billion in FY25 to India's economy and could scale to $216 billion–$318 billion by 2047, the government said on Wednesday, citing a study by the Research and Information System for Developing Countries (RIS).The statement from the Ministry of Ayush said the sector has recorded a 16.91 per cent compound annual growth rate since FY23, supports about 1.76 million livelihoods and generated $1.77 billion in Medical Value Travel revenue. The sector is increasingly contributing to India’s economic growth through healthcare, wellness, employment generation and Medical Value Travel, according to the report released during the 11th Ayurveda Day celebrations in Nagpur.“The findings of this landmark study affirm that Ay...
<div>‘Op Drishti’ reflects Army’s courage, dedication, resolve: J&K L-G</div>

‘Op Drishti’ reflects Army’s courage, dedication, resolve: J&K L-G

Health
Srinagar, Sep 30 (IANS) Jammu and Kashmir Lt Governor Manoj Sinha said on Wednesday that ‘Operation Drishti’ was not just a medical camp, but a reflection of the Army’s courage, dedication, and resolve to serve the nation.The L-G addressed the closing ceremony of Phase-II of the Mega Cataract Surgery Camp under ‘Op Drishti’ at Chinar Auditorium, Badami Bagh Cantonment in Srinagar.He said the 11th mega surgery camp had brought together patients, doctors, medical teams and the Army to provide quality eye care to people who otherwise face difficulties in accessing advanced treatment.He said ‘Op Drishti’ was not merely a medical camp but reflected the Army’s service, courage, resolve and commitment to restoring dignity and improving the lives of people living in remote and border areas.“I expr...
SC questions inflated medicine prices, corporate hospitals’ in-house pharmacy practice

SC questions inflated medicine prices, corporate hospitals’ in-house pharmacy practice

Health
New Delhi, Sep 29 (IANS) The Supreme Court on Tuesday questioned the huge disparity between the maximum retail price (MRP) of medicines and the price at which they are supplied to retailers, asking the Centre why a uniform margin cap could not be prescribed for pharmaceutical products. A bench of Justices Vikram Nath and Sandeep Mehta raised particular concern over cancer medicines carrying an MRP of Rs 27,000 while their price to retailers (PTR) was around Rs 3,000.The apex court also flagged the practice of corporate hospitals requiring patients to purchase medicines from their in-house pharmacies, observing that patients who procure medicines from outside may not be assured treatment."Corporate hospitals say you have to buy from our chemist. If you bring it from outside, we are not assu...
<div>Bengal mulls action against doctors for attending Abhishek’s Sebashray camps without approval</div>

Bengal mulls action against doctors for attending Abhishek’s Sebashray camps without approval

Health
Kolkata, Sep 29 (IANS) The West Bengal Health Department is considering disciplinary action against government doctors attached to state-run medical institutions who allegedly attended and treated patients at Sebashray health camps organised by Trinamool Congress National General Secretary and Diamond Harbour MP Abhishek Banerjee without obtaining prior approval from competent authorities.Sources in the health department said a four-member probe committee, formed to investigate alleged irregularities at the Sebashray health camps, has already begun questioning some government doctors who attended the camps without prior permission from higher authorities. “Depending on the satisfactory level of their replies, the four-member probe committee will decide whether disciplinary proceedings will...
Kerala HC urges Centre to examine patent powers for cancer drugs

Kerala HC urges Centre to examine patent powers for cancer drugs

Health
Kochi, Sep 28 (IANS) The Kerala High Court on Monday asked the Centre to examine whether its powers under Section 100 of the Patents Act could be used to improve access to costly patented life-saving medicines, particularly when such drugs are priced beyond the reach of patients.Justice Harisankar V. Menon observed that invoking the provision was ultimately a policy matter but noted that government intervention could be considered where medicines were being sold at exorbitant prices.Section 100 empowers the Central government to authorise the use of a patented invention for government purposes without the consent of the patent holder.The court did not direct the Centre to invoke the provision in the present case involving expensive breast cancer medicines but asked the government to coll...
Large clinical trial finds 24 weeks of Ashwagandha well tolerated without liver or kidney injury

Large clinical trial finds 24 weeks of Ashwagandha well tolerated without liver or kidney injury

Health
New Delhi, Sep 28 (IANS) A large multicentre clinical study published in Frontiers in Medicine found daily administration of a standardised Ashwagandha root extract for 24 weeks was well tolerated with no evidence of treatment‑related hepatic or renal injury, the government said on Monday.The statement from the Ministry of Ayush said the study published on August 20 is based on a multicentre, randomised, double‑blind, placebo‑controlled trial of a safe prolonged prophylactic use and tolerability of Ashwagandha following COVISHIELD vaccination over 24 weeks.The study found a favourable safety and tolerability profile for the standardised Ashwagandha root extract over the 24-week intervention period, the statement said.“Liver and kidney function parameters remained within the reported refere...